ArticleOncotarget2018

NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma.

Shugo Ueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.